High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$15.0M
$14,999,936
Total Sells (Filtered)
$146M
$146,700,044
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
APGE
M
Apogee Therapeutics, Inc.
Dambkowski Carl
• Officer • Chief Medical Officer
Other
2026-03-04
$94,298
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
Officer • Chief Medical Officer
Other
|
2026-03-04 | $94,298 | M | Form 4 |
|
APGE
S
Apogee Therapeutics, Inc.
Dambkowski Carl
• Officer • Chief Medical Officer
10b5-1 Sell
2026-03-04
$14,652
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2026-03-04 | $14,652 | S | Form 4 |
|
APGE
S
Apogee Therapeutics, Inc.
Dambkowski Carl
• Officer • Chief Medical Officer
10b5-1 Sell
2026-03-04
$149,358
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2026-03-04 | $149,358 | S | Form 4 |
|
APGE
S
Apogee Therapeutics, Inc.
Dambkowski Carl
• Officer • Chief Medical Officer
10b5-1 Sell
2026-03-04
$226,814
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2026-03-04 | $226,814 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CFO
10b5-1 Sell
|
2026-03-02 | $20,829 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CFO
10b5-1 Sell
|
2026-03-02 | $29,094 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CFO
10b5-1 Sell
|
2026-03-02 | $70,027 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CFO
10b5-1 Sell
|
2026-03-02 | $20,481 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2026-02-11 | $481,225 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2026-02-11 | $62,065 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2026-02-11 | $723,662 | S | Form 4 |
|
APGE
S
Apogee Therapeutics, Inc.
Dambkowski Carl
• Officer • Chief Medical Officer
10b5-1 Sell
2026-02-04
$160,967
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2026-02-04 | $160,967 | S | Form 4 |
|
APGE
S
Apogee Therapeutics, Inc.
Dambkowski Carl
• Officer • Chief Medical Officer
10b5-1 Sell
2026-02-04
$13,788
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2026-02-04 | $13,788 | S | Form 4 |
|
APGE
S
Apogee Therapeutics, Inc.
Dambkowski Carl
• Officer • Chief Medical Officer
10b5-1 Sell
2026-02-04
$6,788
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2026-02-04 | $6,788 | S | Form 4 |
|
APGE
S
Apogee Therapeutics, Inc.
Dambkowski Carl
• Officer • Chief Medical Officer
10b5-1 Sell
2026-02-04
$86,838
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2026-02-04 | $86,838 | S | Form 4 |
|
APGE
S
Apogee Therapeutics, Inc.
Dambkowski Carl
• Officer • Chief Medical Officer
10b5-1 Sell
2026-02-04
$93,479
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2026-02-04 | $93,479 | S | Form 4 |
|
APGE
M
Apogee Therapeutics, Inc.
Dambkowski Carl
• Officer • Chief Medical Officer
Other
2026-02-04
$94,298
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
Officer • Chief Medical Officer
Other
|
2026-02-04 | $94,298 | M | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CFO
10b5-1 Sell
|
2026-02-02 | $51,646 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CFO
10b5-1 Sell
|
2026-02-02 | $6,689 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CFO
10b5-1 Sell
|
2026-02-02 | $73,294 | S | Form 4 |
|
APGE
S
Apogee Therapeutics, Inc.
Fairmount Funds Management LLC
• Director
Discretionary SellΔOwn -85.4%
2026-01-22
$133,525,000MEGA
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
Director
Discretionary SellΔOwn -85.4%
|
2026-01-22 | $133,525,000MEGA | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2026-01-14 | $113,242 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2026-01-14 | $676,554 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2026-01-14 | $192,294 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2026-01-14 | $152,788 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2026-01-14 | $447,900 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2026-01-14 | $39,381 | S | Form 4 |
|
APGE
M
Apogee Therapeutics, Inc.
Dambkowski Carl
• Officer • Chief Medical Officer
Other
2026-01-07
$320,612
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
Officer • Chief Medical Officer
Other
|
2026-01-07 | $320,612 | M | Form 4 |
|
APGE
S
Apogee Therapeutics, Inc.
Dambkowski Carl
• Officer • Chief Medical Officer
10b5-1 Sell
2026-01-07
$8,006
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2026-01-07 | $8,006 | S | Form 4 |
|
APGE
M
Apogee Therapeutics, Inc.
Dambkowski Carl
• Officer • Chief Medical Officer
Equity Compensation
2026-01-07
$0
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
Officer • Chief Medical Officer
Equity Compensation
|
2026-01-07 | $0 | M | Form 4 |
|
APGE
S
Apogee Therapeutics, Inc.
Dambkowski Carl
• Officer • Chief Medical Officer
10b5-1 Sell
2026-01-07
$65,287
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2026-01-07 | $65,287 | S | Form 4 |
|
APGE
S
Apogee Therapeutics, Inc.
Dambkowski Carl
• Officer • Chief Medical Officer
10b5-1 Sell
2026-01-07
$1,154,478Large
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2026-01-07 | $1,154,478Large | S | Form 4 |
|
APGE
S
Apogee Therapeutics, Inc.
Dambkowski Carl
• Officer • Chief Medical Officer
10b5-1 Sell
2026-01-07
$227,842
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2026-01-07 | $227,842 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CFO
10b5-1 Sell
|
2025-12-19 | $120,000 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-12-10 | $42,885 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-12-10 | $758,279 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-12-10 | $706,493 | S | Form 4 |
|
APGE
S
Apogee Therapeutics, Inc.
Dambkowski Carl
• Officer • Chief Medical Officer
10b5-1 Sell
2025-12-04
$817,500
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-12-04 | $817,500 | S | Form 4 |
|
APGE
S
Apogee Therapeutics, Inc.
HENDERSON MICHAEL THOMAS
• CEO
10b5-1 Sell
2025-12-04
$3,000,400Large
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-12-04 | $3,000,400Large | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CFO
10b5-1 Sell
|
2025-12-04 | $112,500 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CFO
10b5-1 Sell
|
2025-11-14 | $130,000 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-11-13 | $6,452 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-11-13 | $206,846 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-11-13 | $932,830 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-11-13 | $114,108 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CFO
10b5-1 Sell
|
2025-11-11 | $60,000 | S | Form 4 |
|
APGE
S
Apogee Therapeutics, Inc.
Dambkowski Carl
• Officer • Chief Medical Officer
10b5-1 Sell
2025-11-05
$123,326
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-11-05 | $123,326 | S | Form 4 |
|
APGE
S
Apogee Therapeutics, Inc.
Dambkowski Carl
• Officer • Chief Medical Officer
10b5-1 Sell
2025-11-05
$38,314
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-11-05 | $38,314 | S | Form 4 |
|
APGE
S
Apogee Therapeutics, Inc.
Dambkowski Carl
• Officer • Chief Medical Officer
10b5-1 Sell
2025-11-05
$311,637
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-11-05 | $311,637 | S | Form 4 |
|
APGE
S
Apogee Therapeutics, Inc.
Dambkowski Carl
• Officer • Chief Medical Officer
10b5-1 Sell
2025-11-05
$120,626
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-11-05 | $120,626 | S | Form 4 |
|
APGE
M
Apogee Therapeutics, Inc.
Dambkowski Carl
• Officer • Chief Medical Officer
Other
2025-11-05
$184,252
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
Officer • Chief Medical Officer
Other
|
2025-11-05 | $184,252 | M | Form 4 |
|
APGE
P
Apogee Therapeutics, Inc.
Shah Nimish P
• Director
Discretionary Buy
2025-10-10
$14,999,936MEGA
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
Director
Discretionary Buy
|
2025-10-10 | $14,999,936MEGA | P | Form 4 |
|
APGE
M
Apogee Therapeutics, Inc.
Dambkowski Carl
• Officer • Chief Medical Officer
Other
2025-10-01
$54,521
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
Officer • Chief Medical Officer
Other
|
2025-10-01 | $54,521 | M | Form 4 |
|
APGE
S
Apogee Therapeutics, Inc.
Dambkowski Carl
• Officer • Chief Medical Officer
10b5-1 Sell
2025-10-01
$203,378
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
Officer • Chief Medical Officer
10b5-1 Sell
|
2025-10-01 | $203,378 | S | Form 4 |